EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata

Douglas DiRuggiero, Kristine Kucera

Journal of Drugs in Dermatology · 2026

DOI: 10.36849/jdd.9292 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, 2026. Verfasst von Douglas DiRuggiero und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Alopecia Areata, Janus Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alopecia AreataJanus Kinase InhibitorsHumansTreatment OutcomeQuality of Life

Substanzen

Janus Kinase Inhibitors

Zitieren

APA

DiRuggiero, D., & Kucera, K. (2026). Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9292

Vancouver

DiRuggiero D, Kucera K. Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata. Journal of Drugs in Dermatology. 2026. doi:10.36849/jdd.9292

BibTeX
@article{DiRuggiero2026,
  author = {DiRuggiero, Douglas and Kucera, Kristine},
  title = {Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata},
  journal = {Journal of Drugs in Dermatology},
  year = {2026},
  doi = {10.36849/jdd.9292}
}
Kostenlos starten →